Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000502097 | SCV000594564 | likely benign | not specified | 2016-06-27 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000502097 | SCV003988234 | uncertain significance | not specified | 2023-04-17 | criteria provided, single submitter | clinical testing | The c.1286G>A (p.R429H) alteration is located in exon 11 (coding exon 10) of the EPB41L1 gene. This alteration results from a G to A substitution at nucleotide position 1286, causing the arginine (R) at amino acid position 429 to be replaced by a histidine (H). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |